Belsilver Pharma Consulting
The computed 12-month bankruptcy probability of Belsilver Pharma Consulting is 0.4% (very low). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 7 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro | 11-06-2026 | 2026-00153163 |
| 31-12-2024 | micro | 27-06-2025 | 2025-00190187 |
| 31-12-2023 | micro | 23-07-2024 | 2024-00274070 |
| 31-12-2022 | micro | 21-06-2023 | 2023-00153786 |
| 31-12-2021 | micro | 19-08-2022 | 2022-20303984 |
| 31-12-2020 | micro | 30-08-2021 | 2021-57800286 |
| 31-12-2019 | micro | 27-08-2020 | 2020-45600016 |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 28-08-2018 |
| Status | Active |
| Postal code | 2610 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11051B0051/00L000 | Flanders | 504 m² | 1 · 170 m² | 12.0 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
03-04-2023 Change in the board of directors
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "gedelegeerd_bestuurder",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "FILOTAX",
"address": "2600 Antwerpen-Berchem, Grote Steenweg, 616",
"country": "BE",
"legal_form": null
},
"statutory": "niet_statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "een bijzondere volmacht aan de besloten vennootschap \u201CFILOTAX\u201D, met zetel te 2600 Antwerpen-Berchem, Grote Steenweg, 616, vertegenwoordigd door \u00E9\u00E9n van haar bestuurders, de heer Jean-Louis Verhaert of de Heer Philippe van Dieren, met kantoor op zelfde adres om, met mogelijkheid tot indeplaatsstellin",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Nicolas VERBIST",
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-04-03",
"filing_date": "2023-03-30",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2023-03-27",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0701.816.675",
"name_full": "Belsilver Pharma Consulting",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nicolas VERBIST",
"org_rep_person_name": null,
"person_role_at_subject": "Notaris"
},
"co_filed_documents": [
"de uitgifte van de notulen",
"de geco\u00F6rdineerde tekst der statuten"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Belsilver Pharma Consulting |